Hua Medicine (Shanghai) Ltd.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Hua Medicine (Shanghai) Ltd.은 수익성이 있나요?
Hua Medicine (Shanghai) Ltd.에 부채가 있나요?
Hua Medicine (Shanghai) Ltd.의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$3.41
시가
$3.41
일일 범위
$3.2 - $3.41
52주 범위
$1.24 - $4.95
거래량
5.3M
평균 거래량
3.5M
EPS(TTM)
1.21
배당수익률
--
시가총액
$3.2B
HUA MEDICINE-B란 무엇인가요?
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.